chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day of vac 1/8/2021   at 5:00pm got a bloody nose   about 6:00pm  the chills   went to bed about 9 pm with mild headache.  No arm pain 1/9/2021   sat night at 1:30 am  nose bleed 1/10/2021  3:00 pm another nose bleed All events  held pressure..I can't tell you the last time I had a nose bleed!
Information has been received from a health professional concerning a female who on 01/19/2001 was vaccinated with a second dose of hep B vaccine recombinant. On 01/29/2001, one week after her vaccination, the pt experienced itching and rash. It was noted that the pt had sought medical attention. The healthcare professional also reported two additional female patients who had a similar experience. Additional info has been requested.
DIARRHEA; NO APPETITE; CHILLS; JOINT HURTING; FEVER; ACHES; FLU LIKE SYMPTOMS; SHORTNESS OF BREATH; DIZZINESS; This spontaneous report received from a patient concerned a 73 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included chronic obstructive pulmonary disease, severe bronchitis, arthritis, bad back, and drug allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808978 expiry: 13-JUN-2021) dose was not reported, administered on 06-APR-2021 11:30 for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 104 F. On 07-APR-2021, the subject experienced aches. On 07-APR-2021, the subject experienced flu like symptoms. On 07-APR-2021, the subject experienced shortness of breath. On 07-APR-2021, the subject experienced dizziness. On 07-APR-2021, the subject experienced no appetite. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced joint hurting. On 07-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced diarrhea. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches, shortness of breath, diarrhea, no appetite, and joint hurting on 12-APR-2021, flu like symptoms, dizziness, and chills on 11-APR-2021, and fever on 10-APR-2021. This report was non-serious.
This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FG3527) via an unspecified route of administration in the left arm on 13Nov2021 at 15:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included influenza vaccine (MANUFACTURER UNKNOWN) within 4 weeks of vaccination in left arm from 30Oct2021 and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7830) via an unspecified route of administration in the left arm on 24Mar2021 at 12:00 (at the age of 60-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6704) via an unspecified route of administration in the left arm on 14Apr2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 15Nov2021 at 04:00, the patient experienced muscle and joint pain - severe, severe headache, exhaustion and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events muscle and joint pain - severe, severe headache, exhaustion and nausea was resolving at the time of this report.
Child became extremely irritable and fussy, suffered from stomach pain and gas. Frequent unexplained crying.  Some vacant staring was noticed. Child much less talkative. This lasted for a week.  Irritability and fussiness has continued as of 6/7/12. Child was not smiling as much or as playful.  Began waking several times during the night crying and sleep pattern has been completely interuppted. Appetite began decreasing over the course of several days until she was only eating a few ounces of formula at a time as opposed to 22-25 ounces per day plus baby food 3x a day. Appetite has started to increase as of 6/5/12 Vomitted for no apparent reason on 5/27 (mid-morning), 5/28 (8:30 pm), 5/30 (5:30 pm), 2 x on 5/31 (10:50 am and 4:50 pm). No fever.  Child was checked by a doctor on 3 seperate occasions during one week for signs of infection or illness.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions and concomitant medications was reported. In October 2015, the patient was vaccinated with a dose of ZOSTAVAX injection, subcutaneously (dose, lot #, expiry date and anatomical location were not specified). On 05-AUG-2016, the patient was vaccinated with a second dose of ZOSTAVAX injection, subcutaneously, lot # M018593, expiry date 28-JUN-2017 (dose and anatomical location were not specified). No adverse effects were reported. Product quality complain (PQC) was not involved. Additional information has been requested.
First dose was on may 27 2021; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 27th May 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. No adverse event was reported  The reporter consented to follow up.
I have had multiple bloody noses over multiple days post my COVID-19 vaccine. They were very heavy bloody noses over a long period of time, one of them lasting over thirty minutes and ended up in the urgent care.
Woke up during night after getting the vaccine with Chills, fever, achy-  Took Tylenol about 6:30 am .   Fever came down., but returned. 6 hrs later I took ibuprofen and within 2 hours I begin to feel better. By 7:30 PM on Jan 1st I felt normal.
This case was reported by a pharmacist via sales rep and described the occurrence of injection site pain in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected adult as per vaccine indication. The pharmacist stated some patients had reported pain at the injection site post administration of SHINGRIX. The sales representative tried to clarify to get more specifics, but was only provided this general information. The pharmacist did not agree to have a follow up from GSK.
pt recv vax;w/in 24 hr,devel n & v;may have also devel d, flu like illness, dyspnea & abd cramps; w/in 2-3  days, sx resolved;
Pt. developed his initial symptoms of low back pain within a month of his 3rd anthrax vaccination.  His low back pain was later determined to be due to HLA B-27 positive ankylosing spondylitis.  5/12/09 Medical records received DOS 2/12/08-3/24/09 FINAL DIAGNOSIS: Ankylosing Spondylitis Problems addressed during this time frame have included: open wound, peripheral retinal degeneration, circadian rhythm sleep disorder/jet lag, nonallopathic lesions sacral-sacroiliac, other joint symptoms referrable to pelvis/hip/femur, hip joint pain,sacroilliac region sprain, sacroiliitis, backache, myopia, visual impairment left eye.
Aprox. 10 hrs after vax shots she vommited and was running a 102.7 fever.  The fever spiked at 103.1 and would drop to 101 w/ Tylenol.  The fever lasted 2 days dropping to 101.00 the second day and declined to normal body temp.  She whimpered in pain, wouldn't eat and slept most of the 2 days.
his eye felt irritated; swollen eye; red eye; Sore arm; This is a spontaneous report from a contactable consumer (patient). A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248, expiration date: Apr2021), via an unspecified route of administration in arm on 13Jan2021 02:00 at single dose for COVID-19 immunisation. Medical history included blood pressure (as reported). Concomitant medication included hydrochlorothiazide and lisinopril, both for blood pressure. The patient just took the vaccine on Wednesday (13Jan2021) and had a reaction, not sure if it was from the vaccine or not and he was just calling that in to report that as it can be related. The patient got vaccinated on Wednesday at 2 O' clock and no major issues, just sore arm. However, Friday (15Jan2021) afternoon he had woke from a nap and his eye felt irritated. He was still experiencing a swollen eye. So, he was calling about the swollen eye, red eye. He never had something like this before, didn't take anything that might cause it, the only thing unusual was because he got the vaccine. Treatment included using a cold compress only, not ingesting anything. The outcome of events sore arm, eye felt irritated and red eye was unknown, swollen eye was not recovered.
First symptom: shortness of breath: started during the first 15 mins after shot, but was manageable (have asthma and was comparing to that for difficultly level) Second and third: started 30 to 45 minutes after shot, tightness in chest, no pain. Heart palpitations, pulse not bounding. All symptoms subsided within 1 hour 15 minutes to 1 hour 30 minutes after shot.
Three days after receiving HRIG and Rabies Vaccine, surface numbness started in legs.  Within 2 weeks, progressed to feet, groin, trunk, arms, head.  Total skin surface sensory deficit w/areas of temperature insensitivity.  Pin prick significantly redcued.  Light touch most impacted. Also gastro symptoms (diarrhea, constipation), fasciculations, burning sensations, muscle fatigue.  Also experienced cold/flu symptoms one week after vaccine. Weakness, low grade fever, chest & sinus congestion.
About 20 hours after receiving the COVID vaccine she was tired and lay down to nap. Shortly thereafter she became very dizzy even while lying down. As time went on she started burping loudly and developed nausea. She also has developed a headache and has a low fever of 101.5. This all continues until now, 48 hours after the injection and she is still dizzy in bed with the above symptoms.
My feet had been tired and sore from standing and working a lot anyway but seemed to be calming down. About 24-36 hours after the first injection noticed pain in the ball of my left foot.  Shortly after that swelling began in both feet.  Swelling became worse, doctors conclusion was metatarsalgia. Rest, ice, ibuprofen. Swelling got worse on Friday Jan 29, went to emergency at hospital. Diagnosis was nueroma, given a prescription for prednisone.  Began Prednisone Saturday Jan 30.  Swelling began to subside on Sunday evening. Has been improvement slightly throughout the week but still has not gone down.  Small pockets of dried blood are pooling the bottom of my feet where the swelling was the worst.
Mild soreness in art for about 1 day after first dose About 12 hrs. after receiving 2nd. dose, fatigue, exhaustion, but could not sleep.  I felt cold and had chills with movement (but not severe chills).  Adverse effects subsided after about 12 hours and another 24 hrs. required for complete recovery (36 hrs. all together).
patient received a 0.3mL dose of the Moderna COVID-19 vaccine BIVALENT by intramuscular injection instead of the recommended 0.5mL dose; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (patient received a 0.3mL dose of the Moderna COVID-19 vaccine BIVALENT by intramuscular injection instead of the recommended 0.5mL dose) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .3 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (patient received a 0.3mL dose of the Moderna COVID-19 vaccine BIVALENT by intramuscular injection instead of the recommended 0.5mL dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (patient received a 0.3mL dose of the Moderna COVID-19 vaccine BIVALENT by intramuscular injection instead of the recommended 0.5mL dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (patient received a 0.3mL dose of the Moderna COVID-19 vaccine BIVALENT by intramuscular injection instead of the recommended 0.5mL dose).    Concomitant product use was not provided by the reporter.  It was reported that administrations occurred over the course of approximately 1 month.  The patient had no reported symptoms, no additional doses.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-682550, US-MODERNATX, INC.-MOD-2022-682544, US-MODERNATX, INC.-MOD-2022-682546, US-MODERNATX, INC.-MOD-2022-682548 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-682550:same reporter US-MODERNATX, INC.-MOD-2022-682544:same reporter US-MODERNATX, INC.-MOD-2022-682546:same reporter US-MODERNATX, INC.-MOD-2022-682548:same reporter
Per pt - since day of vaccine of H1N1 and flu (1-27-10) both arms have been painful to move and 'bruise easily'. Pt states taking a daily pain reliever.
01-month-old male patient; fgf; This is a spontaneous report from a non-contactable health care professional. A 1-month-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 06Apr2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fgf (as reported) on Apr2021. The outcome of the event was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot been obtained.; Sender's Comments: Based on temporal assosciation, the causal relationship between BNT162B2 and the event, experiencing fgf cannot be completely ruled out. The impact of this report on benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethic committees, and Investigators, as appropriate.
Pt. received Hep. A, varivax, flu shot on 11/18/08.  He complaned of sore, scratchy throat 24 hours after vaccines, on 2nd day had hives all over body.  Still has hives on third day.  Benedryl given as ordered by Dr. office.
Patient's arm was sore following injection and then had a hard time sleeping due to pain that night. Pain has not gone away after 2 weeks, and has trouble lifting left arm. There was no redness/warmth the day after the injection and left arm appeared the same as right.
I received the shot at 1:11 pm. I felt sorta drunk and not safe to drive by 3 pm. Sorta woozy. By 7 I was  home and fell asleep and did not wake up until 4 pm the next day.   I was sleepy and felt terrible nausea and was sweaty three nights in a row.  By the 2nd night  I had a headache that was unbelievable.  I eventually took Tylenol 48 hrs after the shot and it barely helped the headache. I never ever get sick never have headaches. It was bad. I was also super super irritable and I am generally a happy person. I was so bothered by everyone I was sorta angry at them it was weird. By Sunday night my headache was even worse so bad in my neck on my left side that I had the shot, I could barely move my head. I took Tylenol recommended dose. I finally fell asleep on Sunday night 3 days later midnight sweaty again.   Monday morning I woke up and I never felt better. On top of the world amazing.  I felt not  just good but extra good. Ready to go for it all.  It was a very strange experience for over three days. I typically get the flu shot, I stay healthy and never had an experience like this, I don?t get sick luckily. Any I wanted to share this because it was so strange and no one warned me really. .  I have felt great since and am thankful I had the shot.
Dizziness, Headache, night sweats, congestion Narrative: Per nursing report: "2nd dose of the COVID 19 vaccine on 1/26/21 and around 9pm that night he began to experience night sweats, HA, congestion and a feeling of off balance. He called in 1/27/21 and 1/28/21. He reports that his symptoms are better."
This patient was due for four vaccines after his routine physical. I got the okay from Dr. to inform him of the 3 vaccines he additionally needed which were Influenza, HPV9, and Bexsero  (along with Hep A which was already discussed with Dr. prior). Patient agreed to get all four vaccines. I gave HPV9 and Hep A on his right deltoid intramuscularly.  I was supposed to give influenza and bexsero on his left deltoid. However, I accidentally gave pneumovax instead of Bexsero. Due to similar packaging, I overlooked the vaccine and prepped it as a Bexsero and also gave it intramuscularly.   I informed Dr. and my superiors of the incident that took place. Dr. advised to inform patient that this vaccine is not harmful although it is primarily given to elders or children with compromised immune systems. He states that it is okay for patient to return to office within 2-4 weeks to receive his Bexsero vaccination.  I was unable to reach patient despite attempting to reach him multiple times with number on file. I will make further attempts over the course of the week.
Patient received 2nd done of anthrax vaccine. 2 days later developed marked left upper arm edema/erythema.
Pt recv vax on 2/20/99; following vax pt fainted, lips & face lost color
Information has been received from a physician concerning an 80 year old female patient who on 17-AUG-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (lot# 664275/0960Y). On 16-APR-2010 the patient broke out in shingles when she happened to be in the hospital for another unrelated and unspecified health issue. Name of hospital was unknown. It was also unknown if the shingles prolonged the hospitalization. On an unspecified date, the patient recovered. Additional information has been requested.
Pt received a flu immunization on 10-14-22 at 11 am in her left arm. Later that evening, her arm felt itchy , sore, and bruised. She has received yearly flu shots in the past with no incident. The red patch of skin seems to be growing. She had not taken anything to help with the pain or itching. I recommended benadryl. She can not take ibuprofen. Patient will follow up with her doctor tomorrow if there is no improvement.
Patient rested 30 min post COVID vaccine, and felt dizzy. VS were taken and he was slightly hypotensive [80/50 mm/Hg, HR 76 BPM.] had HD previous day, and took carvedilol that morning.  After additional 15 min VS [70/46 mm/Hg HR 74 BPM.] no better
6/11/22 pt to ED with malaise, fatigue, cough, fever, SOB for past 8 days; admitted; found to be positive for COVID; ABX, dexamethasone, Remdesivir; BiPAP/Vapotherm; DNR/DNI; AKI; hypotensive and bradycardic; pt passed away in the hospital
GAVE MODERNA VACCINE ,SHOULD HAVE BEEN PIFER  VACINE PER AGE ,FINSHED OFF SERIES WITH MODERNA TODAY LOT#939902
7 x 6 cm area erythema right biceps area 24 hours after vaccination
Patients received an expired dose; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.No Medical History information was reported.On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided.No treatment medications were provided.Patient took booster dose.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Sep2022 at 14:00 as dose 5 (booster), single (Lot number: GJ2524) at the age of 72 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 09May2022 at 13:00 as dose 4 (booster), single (Lot number: FJ4989), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Thrombocytopenia" (unspecified if ongoing); "enlarged spleen" (unspecified if ongoing); "littoral cell angioma" (unspecified if ongoing); "Prostate cancer", start date: 2010 (unspecified if ongoing). Concomitant medication(s) included: BENEFIBER FIBER SUPPLEMENT, start date: 19Aug2021; PRESERVISION AREDS 2, start date: 08Jan2020. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received Paxlovid from 01Jun2023 to 05Jun2023 for treatment of COVID-19. Brand of concomitant medication PreservisionAreds2 was Bausch & Lomb. Patient got mild Covid rebound symptoms on 15Jun2023 at 08:00 PM with outcome of not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300223853 same patient, different drugs and events;
Pt. said she had a little bump and felt "funny" I checked up on pt. 9/22 and she stated she felt better.